Recent Advances in Understanding and Mitigating Adipogenic and Metabolic Effects of Antipsychotic Drugs

Although offering many benefits for several psychiatric disorders, antipsychotic drugs (APDs) as a class have a major liability in their tendency to promote adiposity, obesity, and metabolic dysregulation in an already metabolically vulnerable population. The past decade has witnessed substantial re...

Descripción completa

Detalles Bibliográficos
Autores principales: Gohlke, Julia M., Dhurandhar, Emily J., Correll, Christoph U., Morrato, Elaine H., Newcomer, John W., Remington, Gary, Nasrallah, Henry A., Crystal, Stephen, Nicol, Ginger, Allison, David B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Research Foundation 2012
Materias:
Psychiatry
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3385013/
https://www.ncbi.nlm.nih.gov/pubmed/22754543
http://dx.doi.org/10.3389/fpsyt.2012.00062

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3385013/
https://www.ncbi.nlm.nih.gov/pubmed/22754543
http://dx.doi.org/10.3389/fpsyt.2012.00062

Ejemplares similares